Peptides, Compounding, and the Regulatory Maze Pharmacies Need to Understand
The growing peptide market is creating regulatory complexity for compounders, prescribers, wellness clinics, and pharmacies navigating FDA rules.
May 10, 2026 / 13 min readClinical
Coverage for pharmacies growing clinical services, patient engagement, testing, adherence, and care delivery programs.
Opioid prescribing has changed dramatically, leaving pharmacies to balance compliance, patient care, documentation, and practical access concerns.
May 10, 2026 / 5 min read
GLP-1 demand affects more than dispensing volume. It influences patient questions, prescriber communication, compounding risk, inventory planning, documentation,…
May 10, 2026 / 4 min read